CG Oncology, Inc. (CGON)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-08) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-27) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-14) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-08) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-28) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Condensed Balance Sheets | ||
| Consolidated Balance Sheets | ||
| Condensed Balance Sheets (P) | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Stockholders' Equity | — |
|
| Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit | — |
|
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit | — |
|
| Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (P) | — |
|
| Unaudited Condensed Statements of Cash Flows | — |
|
| Condensed Statements of Cash Flows (P) | ||
| Consolidated Statements of Cash Flows (P) | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Acquisition of Biovire | ||
| Commitments and Contingencies | ||
| Common Stock | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Debt | ||
| Description of Business and Basis of Presentation | ||
| Employee Stock Purchase Plan | ||
| Fair Value Measurements | ||
| Goodwill and Intangibles, Net | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| License and Collaboration Agreements | ||
| Net Loss Per Share Attributable To Common Stockholders | ||
| Note Receivable | — |
|
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | ||
| Redeemable Convertible Preferred Stock | — |
|
| Related Parties | ||
| Segment Disclosures | ||
| Stock-based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||